Accretive Wealth Partners’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-63,150
Closed -$170K 139
2024
Q1
$170K Buy
+63,150
New +$170K 0.08% 135